Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Pashayan

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
Plos Medicine|December 21, 2019
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling studyTom Callender, Mark Emberton, Steve Morris, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2013
Incorporating genomics into breast and prostate cancer screening: assessing the implicationsSusmita Chowdhury, Tom Dent, Nora Pashayan, et al.
Frontiers in Public Health|March 20, 2023
Represent: A community engagement roadmap to improve participant representation in cancer early detection research: An Oregon case studyJessica Currier, Ignacia Arteaga, Hannah Turner-Uaandja, et al.
European Radiology|April 2, 2026
Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
European Radiology|January 16, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
Journal of Medical Screening|July 1, 2009
Stage shift in PSA-detected prostate cancers - effect modification by Gleason scoreNora Pashayan, Paul Pharoah, David E Neal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2021
Potential of polygenic risk scores for improving population estimates of women's breast cancer genetic risksMichael Wolfson, Steve Gribble, Nora Pashayan, et al.
Cancer Epidemiology|August 20, 2010
Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidenceNora Pashayan, Paul Pharoah, László Tabár, et al.
Journal of Public Health (Oxford, England)|August 13, 2015
Evaluation of recruitment and selection for specialty training in public health: interim results of a prospective cohort study to measure the predictive validity of the selection processNora Pashayan, Selena Gray, Celia Duff, et al.
International Journal of Cancer|May 26, 2010
PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progressionNora Pashayan, Paul Pharoah, David E Neal, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Plos Medicine|December 21, 2019
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling studyTom Callender, Mark Emberton, Steve Morris, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2013
Incorporating genomics into breast and prostate cancer screening: assessing the implicationsSusmita Chowdhury, Tom Dent, Nora Pashayan, et al.
Frontiers in Public Health|March 20, 2023
Represent: A community engagement roadmap to improve participant representation in cancer early detection research: An Oregon case studyJessica Currier, Ignacia Arteaga, Hannah Turner-Uaandja, et al.
European Radiology|April 2, 2026
Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
European Radiology|January 16, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
Journal of Medical Screening|July 1, 2009
Stage shift in PSA-detected prostate cancers - effect modification by Gleason scoreNora Pashayan, Paul Pharoah, David E Neal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2021
Potential of polygenic risk scores for improving population estimates of women's breast cancer genetic risksMichael Wolfson, Steve Gribble, Nora Pashayan, et al.
Cancer Epidemiology|August 20, 2010
Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidenceNora Pashayan, Paul Pharoah, László Tabár, et al.
Journal of Public Health (Oxford, England)|August 13, 2015
Evaluation of recruitment and selection for specialty training in public health: interim results of a prospective cohort study to measure the predictive validity of the selection processNora Pashayan, Selena Gray, Celia Duff, et al.
International Journal of Cancer|May 26, 2010
PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progressionNora Pashayan, Paul Pharoah, David E Neal, et al.
Pageof 18